deltatrials
Terminated PHASE4 INTERVENTIONAL NCT00245791

Urinary Tract Infection Study With the Antibiotic Levofloxacin Given at a Higher Dose Over a Shorter Period of Time

TREATMENT OF COMPLICATED URINARY INFECTION WITH FIVE DAY HIGH DOSE LEVOFLOXACIN

Sponsor: University of Manitoba

Interventions Levofloxacin
Updated 5 times since 2017 Last updated: Jun 2, 2015 Started: Oct 31, 2004 Completion: Jul 31, 2005
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

This trial was terminated. No reason was provided.

A PHASE4 clinical study on Complicated Urinary Infection, this trial is terminated or withdrawn. The trial is conducted by University of Manitoba and has accumulated 5 data snapshots since 2004. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotTerminated~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotTerminated~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – present · 23 months · monthly snapshotTerminated

Change History

5 versions recorded
  1. Sep 2024 — Present [monthly]

    Terminated PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE4

  3. Jan 2021 — Jul 2024 [monthly]

    Terminated PHASE4

  4. Jun 2018 — Jan 2021 [monthly]

    Terminated PHASE4

  5. Jan 2017 — Jun 2018 [monthly]

    Terminated PHASE4

    First recorded

Oct 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • University of Manitoba
Data source: University of Manitoba

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations